Virology News and Research

Latest Virology News and Research

Preliminary results from Boehringer Ingelheim’s volasertib Phase II study on AML

Boehringer Ingelheim Pharmaceuticals, Inc. today reported preliminary results from the randomized Phase II part of a Phase I/II study involving the company's investigational compound volasertib in newly diagnosed patients with acute myeloid leukemia (AML) considered ineligible for intensive remission induction therapy.

11 Dec 2012

Boston College professor to research into new drugs that can prevent onset of toxoplasmosis

The American Cancer Society has awarded a four-year, $720,000 grant to Boston College Associate Professor of Biology Marc-Jan Gubbels for research into potential new drugs that can prevent the onset of toxoplasmosis in cancer patients with weakened immune systems.

10 Dec 2012

Severe RSV disease may impair innate immune response in infants

Infants with severe lower respiratory tract infection caused by respiratory syncytial virus (RSV) may have a dysfunctional innate immune response that relates to the severity of their disease.

10 Dec 2012

Risk factors revealed for anti-tuberculosis drug hepatotoxicity

The risk for hepatotoxicity among patients treated with anti-tuberculosis drugs is affected by gender, ethnicity, and the presence of genetic polymorphisms, say Argentinean researchers.

10 Dec 2012

Despite effective anti-viral drugs, majority of HCV patients remain untreated

Just 20 percent of people infected with the hepatitis C virus (HCV) begin the recommended treatment regimen and less than 5 percent go on to successfully overcome the virus, according to a new review in General Hospital Psychiatry.

10 Dec 2012

U.S. government's draft guidance on funding for H5N1 research receives 'mixed reception,' Science reports

"Researchers are giving a mixed reception to a draft U.S. government plan to do more stringent funding reviews of certain kinds of H5N1 avian influenza research -- and perhaps even require some studies to be kept secret," Science reports.

8 Dec 2012

IQWiG investigates benefits of rilpivirine for HIV treatment

Since the start of 2012, a new drug called rilpivirine has been available for adult patients infected with the human immunodeficiency virus type 1 (HIV-1). It is marketed by two different pharmaceutical companies, by one as a single agent (trade name Edurant-) and by the other as a fixed combination with other HIV drugs (trade name Eviplera-).

8 Dec 2012

International community should 'not forget' importance of treatment, care for children with HIV

The "progress and momentum" behind stopping mother-to-child HIV transmission is "reason to celebrate," Charles Lyons, president and CEO of the Elizabeth Glaser Pediatric AIDS Foundation, and Peter Twyman, CEO of Keep a Child Alive, write in The Hill's "Congress Blog."

8 Dec 2012

Scientists isolate previously unknown protein in skeletal muscle

Scientists at Dana-Farber Cancer Institute have isolated a previously unknown protein in muscles that spurs their growth and increased power following resistance exercise. They suggest that artificially raising the protein's levels might someday help prevent muscle loss caused by cancer, prolonged inactivity in hospital patients, and aging.

7 Dec 2012

Global Post examines unproven, unscientific HIV treatments

Global Post examines how "many HIV patients around the world continue to turn to more affordable but far less reliable treatments" instead of proven -- but more expensive -- therapies, such as antiretroviral (ARV) drugs.

6 Dec 2012

Vaccine-derived polio outbreak shows gaps in immunization coverage in Pakistan

Though "Pakistan has made a lot of progress this year in wiping out polio," a "recent outbreak of polio there has health officials concerned about the overall effectiveness of the effort to eliminate polio in that country," NPR's "Shots" blog reports.

6 Dec 2012

Tenofovir DF safe and effective in treating adolescents with HBV

A recent clinical trial found that the adult antiviral drug, tenofovir disoproxil fumarate (tenofovir DF), is safe and effective in treating adolescents with hepatitis B virus (HBV). Trial results published in the December issue of Hepatology, a journal of the American Association for the Study of Liver Diseases (AASLD), show that tenofovir DF suppressed HBV in 89% of pediatric participants.

6 Dec 2012

WHO assists Middle East authorities with coronavirus investigation

The World Health Organization has sent a team to Jordan at the request of the country’s Ministry of Health to help investigate the emergence of a novel coronavirus that resulted in the deaths of two people earlier this year, and to assist with further epidemiologic surveillance.

5 Dec 2012

Children with HIV more likely to develop atherosclerosis

Children with HIV have a 2.5 fold increased risk of atherosclerosis, according to research presented at EUROECHO and other Imaging Modalities 2012. Antiretroviral treatment, lipid lowering drugs and prevention with healthy lifestyles are needed to prevent early death from cardiovascular disease.

5 Dec 2012

New method can generate stable human mesenchymal stem cells for bone engineering

Human mesenchymal stem cells (hMSCs) can develop into bone cells and are useful for tissue engineering and regeneration. However, when grown in the laboratory they quickly lose their ability to continue dividing and they die.

5 Dec 2012

BBC News examines HIV/AIDS in Iran

BBC News examines HIV/AIDS in Iran, writing, "In the 2000s, Iran became known as the region's leader in the fight against AIDS. Each year, the government allocates millions of dollars to prevent and manage the disease, and government-sponsored clinics across the country help battle it."

5 Dec 2012

Natural killer cell response detrimental to glioblastoma virotherapy

For the first time, researchers have demonstrated that the response of natural killer (NK) cells is detrimental to glioblastoma virotherapy, a novel way of treating malignant brain cancer by injecting a virus into the tumor.

5 Dec 2012

Bioinformaticians use molecular simulations to explain specific step in HIV virion maturation

Bioinformaticians at IMIM (Hospital del Mar Medical Research Institute) and UPF (Pompeu Fabra University) have used molecular simulation techniques to explain a specific step in the maturation of the HIV virions, i.e., how newly formed inert virus particles become infectious, which is essential in understanding how the virus replicates.

5 Dec 2012

Virginia Women's Center to participate in new HPV and cervical cancer vaccine clinical trial

Virginia Women's Center has been selected to participate in a nationwide clinical trial, one that will ultimately hope to prevent the human papillomavirus virus (HPV) from progressing into cervical cancer and treat women who have HPV and the precancerous lesions associated with it. The Richmond-area OB-GYN practice has participated in over 50 clinical research studies since 1997, all of which have contributed to the future of safe and effective medicine for women.

4 Dec 2012

Opinion pieces, editorial address global AIDS response

U.S. Secretary of State Hillary Clinton on Thursday announced the Obama administration's "President's Emergency Plan for AIDS Relief (PEPFAR) Blueprint: Creating an AIDS-free Generation", and the international community recognized World AIDS Day on December 1.

4 Dec 2012

Virology News and Research

Latest Virology News and Research

Preliminary results from Boehringer Ingelheim’s volasertib Phase II study on AML

Boston College professor to research into new drugs that can prevent onset of toxoplasmosis

Severe RSV disease may impair innate immune response in infants

Risk factors revealed for anti-tuberculosis drug hepatotoxicity

Despite effective anti-viral drugs, majority of HCV patients remain untreated

U.S. government's draft guidance on funding for H5N1 research receives 'mixed reception,' Science reports

IQWiG investigates benefits of rilpivirine for HIV treatment

International community should 'not forget' importance of treatment, care for children with HIV

Scientists isolate previously unknown protein in skeletal muscle

Global Post examines unproven, unscientific HIV treatments

Vaccine-derived polio outbreak shows gaps in immunization coverage in Pakistan

Tenofovir DF safe and effective in treating adolescents with HBV

WHO assists Middle East authorities with coronavirus investigation

Children with HIV more likely to develop atherosclerosis

New method can generate stable human mesenchymal stem cells for bone engineering

BBC News examines HIV/AIDS in Iran

Natural killer cell response detrimental to glioblastoma virotherapy

Bioinformaticians use molecular simulations to explain specific step in HIV virion maturation

Virginia Women's Center to participate in new HPV and cervical cancer vaccine clinical trial

Opinion pieces, editorial address global AIDS response

Microplate-based assays in virology research eBook eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting